132 related articles for article (PubMed ID: 25538773)
21. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
Weston MC; Anderson N; Peachell PT
Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
[TBL] [Abstract][Full Text] [Related]
22. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate.
Peachell PT; MacGlashan DW; Lichtenstein LM; Schleimer RP
J Immunol; 1988 Jan; 140(2):571-9. PubMed ID: 2447182
[TBL] [Abstract][Full Text] [Related]
23. In vitro desensitization of beta-adrenoceptors in guinea pig trachea: interactions between beta-adrenoceptor agonists and influence of adenosine and other drugs.
Matran R; Naline E; Advenier C; Duroux P
Fundam Clin Pharmacol; 1989; 3(2):103-13. PubMed ID: 2566570
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
Church MK; Hiroi J
Br J Pharmacol; 1987 Feb; 90(2):421-9. PubMed ID: 2435353
[TBL] [Abstract][Full Text] [Related]
25. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung.
Bastan R; Peirce MJ; Peachell PT
Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
Okayama Y; Church MK
Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
[TBL] [Abstract][Full Text] [Related]
27. Presence of functionally active beta-adrenoceptors in rat mast cells. Correlation between (--)[3H]-dihydroalprenolol binding and inhibition of histamine release.
Masini E; Fantozzi R; Blandina P; Galli A; Bani-Sacchi T; Giotti A; Zilletti L; Mannaioni PF
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):171-6. PubMed ID: 6185855
[TBL] [Abstract][Full Text] [Related]
28. Regulation of human skin mast cell histamine release by PDE inhibitors.
Eskandari N; Bastan R; Peachell PT
Allergol Immunopathol (Madr); 2015; 43(1):37-41. PubMed ID: 24231152
[TBL] [Abstract][Full Text] [Related]
29. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
30. Single cell analysis of free cytosolic calcium changes in human lung mast cells--II. The relationship between desensitization and the cellular regulation of calcium changes.
MacGlashan D
Mol Immunol; 1991 Jun; 28(6):585-97. PubMed ID: 1713645
[TBL] [Abstract][Full Text] [Related]
31. Mast cell beta2-adrenoceptors.
Kay LJ; Peachell PT
Chem Immunol Allergy; 2005; 87():145-153. PubMed ID: 16107769
[TBL] [Abstract][Full Text] [Related]
32. Characterization of protein serine/threonine phosphatase activities in human lung mast cells and basophils.
Peirce MJ; Munday MR; Peachell PT
Br J Pharmacol; 1998 Nov; 125(5):1095-101. PubMed ID: 9846650
[TBL] [Abstract][Full Text] [Related]
33. The effects of S1319, a novel marine sponge-derived beta2-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells.
Suzuki H; Ueno A; Takei M; Shindo K; Higa T; Fukamachi H
Inflamm Res; 2000 Feb; 49(2):86-94. PubMed ID: 10738947
[TBL] [Abstract][Full Text] [Related]
34. Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor.
Cruse G; Yang W; Duffy SM; Chachi L; Leyland M; Amrani Y; Bradding P
J Allergy Clin Immunol; 2010 Jan; 125(1):257-63.e1-5. PubMed ID: 19864009
[TBL] [Abstract][Full Text] [Related]
35. Resistance of beta 2-adrenoceptor-mediated responses of lung strips to desensitization by long-term agonist exposure--comparison with atrial beta 1-adrenoceptor-mediated responses.
Herepath ML; Broadley KJ
Eur J Pharmacol; 1992 May; 215(2-3):209-19. PubMed ID: 1356791
[TBL] [Abstract][Full Text] [Related]
36. Biochemical analysis of desensitization of mouse mast cells.
Ishizaka T; Sterk AR; Daeron M; Becker EL; Ishizaka K
J Immunol; 1985 Jul; 135(1):492-501. PubMed ID: 2582046
[TBL] [Abstract][Full Text] [Related]
37. Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue.
Hauck RW; Harth M; Schulz C; Präuer H; Böhm M; Schömig A
Br J Pharmacol; 1997 Aug; 121(8):1523-30. PubMed ID: 9283684
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
39. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
Eleno N; Gajate E; Macias J; Garay RP
Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
[TBL] [Abstract][Full Text] [Related]
40. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
